55
Participants
Start Date
September 30, 2010
Primary Completion Date
January 30, 2015
Study Completion Date
January 30, 2019
Bevacizumab
Cyclophosphamide
Methotrexate
Lifestyle: Diet
Lifestyle: Diet+Exercise
Memorial Sloan Kettering Cancer Center, New York
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill
Duke University Medical Center, Durham
University of Alabama at Birmingham, Birmingham
Vanderbilt-Ingram Cancer Center, Nashville
Indiana Unversity Simon Cancer Center, Indianapolis
Faulkner Hospital, Boston
Dana-Farber Cancer Institute, Boston
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center, Milford
Collaborators (1)
Brigham and Women's Hospital
OTHER
Beth Israel Deaconess Medical Center
OTHER
Translational Breast Cancer Research Consortium
OTHER
Genentech, Inc.
INDUSTRY
Dana-Farber Cancer Institute
OTHER